Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1376-1387

  Karmakar, Subir ^a   Paul, Joydeep ^a   De, Tripti ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

CD1d; Glycosphingolipid; iNKT cell; Lipid raft; Parasitic protozoan

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GLYCOSPHINGOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CALCIUM MOBILIZATION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG BINDING; HAMSTER; IN VITRO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; LIPID RAFT; MACROPHAGE; MEMBRANE FLUIDITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; BLOTTING, WESTERN; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSYLCERAMIDES; GLYCOSPHINGOLIPIDS; IMMUNOLOGICAL SYNAPSES; ISOELECTRIC FOCUSING; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; NATURAL KILLER T-CELLS;

EID: 79955128728     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040981     Document Type: Article

References (51)

1. Antoine, J. C., Prina, E., Courret, N. and Lang, T., Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv. Parasitol. 2004. 58: 1-68.
2. Olivier, M. and Gregory, D. J., Leishmania: After the Genome. In Myler, P. J. and Fasel, N. (Eds.), Interactions Between Leishmania and the Host Macrophage, Caister Academic Press, Norfolk, UK, 2008, Chapter 11.
3. Sen, E., Chattopadhyay, S., Bandopadhyay, S., De, T. and Roy, S., Macrophage heterogeneity, antigen presentation, and membrane fluidity: implications in visceral leishmaniasis. Scand. J. Immunol. 2001. 53: 111-120.
4. Pinheiro, R. O., Pinto, E. F., Benedito, A. B., Lopes, U. G. and Rossi-Bergmann, B., The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis. An. Acad. Bras. Cienc. 2004. 76: 519-527.
5. Chakraborty, D., Banerjee, S., Sen, A., Banerjee, K. K., Das, P. and Roy, S., Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J. Immunol. 2005. 175: 3214-3224.
6. Anderson, H. A., Hiltbold, E. M. and Roche, P. A., Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 2000. 1: 156-162.
7. Lang, G. A., Maltsev, S. D., Besra, G. S. and Lang, M. L., Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology 2004. 112: 386-396.
8. Hiltbold, E. M., Poloso, N. J. and Roche, P. A., MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J. Immunol. 2003. 170: 1329-1338.
9. Sullivan, B. A., Nagarajan, N. A., Wingender, G., Wang, J., Scott, I., Tsuji, M., Franck, R. W. et al., Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J Immunol. 2010. 184: 141-153.
10. Bhaumik, S. K., Singh, M. K., Karmakar, S. and De, T., Immunostimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera. Mol. Biochem. Parasitol. 2008. 159: 121-129.
11. Lang, G. A., Exley, M. A. and Lang, M. L., The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 2006. 119: 116-125.
12. Park, Y. K., Lee, J. W., Ko, Y. G., Hong, S. and Park, S. H., Lipid rafts are required for efficient signal transduction by CD1d. Biochem. Biophys. Res. Commun. 2005. 327: 1143-1154.
13. Gelin, C., Sloma, I., Charron, D. and Mooney, N., Regulation of MNC II and CD1d antigen presentation: from ubiquity to security. J. Leukoc. Biol. 2009. 85: 215-224.
14. Vin, N., Long, X., Goff, R. D., Zhou, D., Cantu III, C., Mattner, J., Mezard, P. S. et al., Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells. ACS Chem. Biol. 2009. 4: 191-197.
15. Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T. et al., Glycolipid antigen processing for presentation by CD1d molecules. Science 2001. 291: 664-667.
16. Harada, S., Yokomizo, K., Monde, K., Maeda, Y. and Yusa, K., A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator. Cell. Microbiol. 2007. 9: 196-203.
17. Florence, W. C., Bhat, R. K. and Joyce, S., CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences. Expert Rev. Mol. Med. 2008. 10: e20.
18. Godfrey, D. I., McCluskey, J. and Rossjohn, J., CD1d antigen presentation: treats for NKT cells. Nat. Immunol. 2005. 6: 754-756.
19. Radermacher, A. N. and Crabtree, G. R., Monster protein controls calcium entry and fights infection. Immunity 2008. 28: 13-24.
20. Behar, S. M. and Porcelli, S. A., CD1d-restricted T cells in host defense to infectious diseases. Curr. Top. Microbiol. Immunol. 2007. 314: 215-250.
21. Speak, A. O., Cerundolo, V. and Platt, F. M., CD1d presentation of glycolipids. Immunol. Cell Biol. 2008. 86: 588-597.
22. Peng, W., Martaresche, C., Escande-Beillard, N., Cedile, O., Reynier-Vigouroux, A. and Boucraut, J., Influence of lipid rafts on CD1d presentation by dendritic cells. Mol. Membr. Biol. 2007. 24: 475-484.
23. Pucadyil, T. J. and Chattopadhyay, A., Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol. 2007. 23: 49-53.
24. Soares, N. M., Leal, T. F., Fiúza, M. C., Reis, E. A., Souza, M. A., Dos-Santos, W. L. and Pontes-de-Carvalho, L., Plasma lipoproteins in visceral leishmaniasis and their effect on Leishmania-infected macrophages. Parasite Immunol. 2010. 32: 259-266.
25. Shamshiev, A. T., Ampenberger, F., Ernst, B., Rohrer, L., Marsland, B. J. and Kopf, M., Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 2007. 204: 441-452.
26. Simons, M., Friedrichson, T., Schulz, J. B., Pitto, M., Masserini, M. and Kurzchalia, T. V., Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol. Biol. Cell 1999. 10: 3187-3196.
27. Kabouridis, P. S., Lipid rafts in T cell receptor signaling. Mol. Membr. Biol. 2006; 23: 49-57.
28. Gupta, G. and Surolia, A., Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 2010. 584: 1634-1641.
29. Thompson, T. E. and Tillack, T. W., Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells. Annu. Rev. Biophys. Biophys. Chem. 1985. 14: 361-386.
30. Salio, M., Silk, J. D. and Cerundolo, V., Recent advances in processing and presentation of CD1 bound lipid antigens. Curr. Opin. Immunol. 2010. 22: 81-88.
31. Gombos, I., Kiss, E., Detre, C., Laszlo, G. and Matko, J., Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol. Lett. 2006. 104: 59-69.
32. Robinson, J. H. and Delvig, A. A., Diversity in MHC class II antigen presentation. Immunology 2002. 105: 252-262.
33. Lalazar, G., Ben Ya'acov, A., Eliakim-Raz, N., Livovsky, D. M., Pappo, O., Preston, S., Zolotarov, L. et al., Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+T lymphocyte trapping. J. Lipid Res. 2008. 49: 1884-1893.
34. Peters, N. and Sacks, D., Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol. Rev. 2006. 213: 159-179.
35. Tamma, S. L., Sundaram, S. K., Lev, M. and Coico, R. F., Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells. Biochem. Biophys. Res. Commun. 1996. 220: 916-921.
36. Sharom, F. J. and Grant, C. W., A model for ganglioside behaviour in cell membranes. Biochim. Biophys. Acta 1978. 507: 280-293.
37. Bertoli, E., Masserini, M., Sonnino, S., Ghidoni, R., Cestaro, B. and Tettamanti, G., Electron paramagnetic resonance studies on the fluidity and surface dynamics of egg phosphatidylcholine vesicles containing gangliosides. Biochim. Biophys. Acta 1981. 647: 196-202.
38. Hakomori, S., Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 1981. 50: 733-764.
39. Yamakawa, T. and Nagai, Y., Glycolipids at the cell surface and their biological significance. Trends Biochem. Sci. 1978. 3: 128-131.
40. Hakomori, S., Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985. 45: 2405-2414.
41. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M. and Dustin, M. L., The immunological synapse: a molecular machine controlling T cell activation. Science 1999. 285: 221-227.
42. Brown, D. A. and London, E., Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 2000. 275: 17221-17224.
43. Amprey, J. L., Im, J. S., Turco, S. J., Murray, H. W., Illarinov, P. A., Besra, G. S., Porcelli, S. A. et al., A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 2004. 200: 895-904.
44. Ahuja, S. S., Reddick, R. L., Sato, N., Montalbo, E., Kostecki, V., Zhao, W., Dolan, M. J. et al., Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 1999. 163: 3890-3897.
45. Bhaumik, S. K., Naskar, K. and De, T., Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Eur. J. Immunol. 2009. 39: 2146-2160.
46. De, T. and Roy, S., Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyltransferase with loss of parasite virulence. J. Parasitol. 1999. 85: 54-59.
47. De-Majumdar, T., Leishmania donovani: purification and partial characterization of a glycophosphosphingolipid antigen expressed on promastigote surface. Exp. Parasitol. 1992. 74: 251-260.
48. Shinitzky, M. and Barenholz, Y., Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta 1978. 515:367-394.
49. Sarkar, D. and Bhaduri, A., Temperature-induced rapid increase in cytoplasmic free Ca2+in pathogenic Leishmania donovani promastigotes. FEBS Lett. 1995. 375: 83-86.
50. Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. F. and Baumruker, T., Glycosphingolipid-induced relocation of Lyn and Syk into detergent-resistant membranes results in mast cell activation. J. Immunol. 2000. 164: 5389-5397.
51. Blank, N., Gabler, C., Schiller, M., Kriegel, M., Kalden, J. R. and Lorenz, H. M., A fast, simple and sensitive method for the detection and quantification of detergent-resistant membranes. J. Immunol. Methods 2002. 271: 25-35.